DW1807

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW1807, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma [Phase 3]